Alex's Lemonade Stand Foundation (ALSF)
2015 Innovation GrantALSF's innovation grants are designed as seed funding for researchers with a novel approach to pediatric oncology scientific investigation. Innovation grants will support research proposals to be carried out by investigators who are already established, have a track record of peer-reviewed publications, and evidence of successfully competing for extramural funding.
Amount: $125,000/ year for 2 years
Deadline: LOI; November 3, 2014
American Association for Cancer Research (AACR)-Stand Up to Cancer (SU2C)-American Cancer Society (ACS)
Call for IdeasAACR, on behalf of SU2C-ACS, calls upon members of the cancer community to contribute their ideas to the Translational Research Dream Team grant. The project should include therapeutic interventions for lung cancer, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic Dream Team of expert investigators. Each Team will consist of a Dream Team Leader (DTL), a Dream Team Co-leader, at least three additional Dream Team Principals (DTP), and at least two Advocates. Dream Team Leader, Co-leader and Principals must be from different institutions. A scientist may not be funded on more than one SU2C-sponsored Dream Team grant. No more than 50% of the Principal's (including Leader and Co-leader) from a previous Dream Team may apply as a group on a new Dream Team proposal.
Amount:$20,000,000 over 3 years
Deadline: LOI; November 5, 2014
American Association for Cancer Research (AACRR)-Stand Up to Cancer (SU2C)-Ovarian Cancer Research Fund (OCRF)-Ovarian Cancer National Alliance (OCNA)- National Ovarian Cancer Coalition (NOCC)
Call for IdeasAACR invites submission of ideas for a translational cancer research project that addresses critical problems in cancer and positively impacts patients in the near future. The project should include therapeutic interventions for ovarian cancer, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, synergistic Dream Team of expert investigators. Each Team will consist of a Dream Team Leader (DTL), a Dream Team Co-leader, no more than four additional Dream Team Principals (DTP), and at least two Advocates. Dream Team Leader, Co-leader and Principals must be from different institutions. To maximize creativity, innovation, and collaboration, the Dream Team must include laboratory and clinical researchers, senior and/or young investigators, and senior scientists who have not worked together in the past.
Amount: $3,000,000 over 3 years
Deadline: LOI; November 7, 2014
Free to Breathe
Free to Breathe 2015 Research Grant To Prevent or Stop Lung Cancer MetastasisFree to Breathe supports high-impact and innovative lung cancer research within this area of emphasis that will result in clinical translation (e.g. clinical trial) by the end of the 3-year award period. The ultimate goal is to fund research that will result in treatments for lung cancer patients and increase survival. Applications will only be accepted from PI's engaged in non-small cell or small cell lung cancer research.
Amount: $600,000 over 3 years
Deadline: LOI; November 7, 2014
Melanoma Research Alliance (MRA)
MRA Established Investigator AwardsMRA accelerates the pace of scientific discovery and translation in order to eliminate suffering and death due to melanoma. MRA is soliciting proposals that address the gap in translational science; turning scientific discoveries into tools and/or treatments for high risk individuals and melanoma patients. An investigator may serve as PI on only one proposal submitted to the MRA under any of the mechanisms in this cycle. This includes PIs on team science awards.
Amount: $125,000/ year for 2-3 years
Deadline: November 11, 2014
Melanoma Research Alliance (MRA)-Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb-MRA Established Investigator Awards in ImmunotherapyThrough the generous support of BMS, MRA is offering awards for established investigators to conduct projects supported by preliminary data and focused on advancing the immunotherapies in melanoma. Any applicant in this Established Investigator Award category proposing research focused in the field of immunotherapy may be considered for this Special Opportunity.
Amount: $125,000/ year for 2-3 years
Deadline: November 11, 2014
Melanoma Research Alliance (MRA)
MRA Pilot AwardsMRA Pilot Awards are designed to establish proof-of-concept for potentially transformative ideas from established investigators. Investigators who are past the initial 4 years of their first academic faculty appointment will be considered.
Amount: $50,000/ year for 2 years
Deadline: November 11, 2014
Melanoma Research Alliance (MRA)-Society for Immunotherapy of Cancer (SITC),
Society for Immunotherapy of Cancer-MRA Pilot AwardIn collaboration with SITC, MRA will jointly support a Pilot Award for investigators who are past the initial 4 years of their first academic faculty appointment to conduct potentially transformative pilot studies in the area of immunotherapy. Applicants should submit to the general Pilot Award program, and any applicant in this category proposing research focused in the field of immunotherapy will be considered for this Special Opportunity.
Amount: $50,000/ year for 2 years
Deadline: November 11, 2014
Melanoma Research Alliance (MRA)-Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb-MRA Team Science Awards in ImmunotherapyMRA is offering awards for multidisciplinary teams of two or more established PI's to conduct projects with the potential to lead to transformative advances in melanoma immunotherapies. An investigator may serve as a PI, including Administrative PI and all collaborating P'Is, on only one proposal. Each team must include at least one Young Investigator as a co-investigator. An investigator may only be the designated Young Investigator on one proposal in the team science category. However, a Young Investigator Award applicant may be the designated Young Investigator on only one team science application.
Amount: $900,000 over 2-3 years
Deadline: November 21, 2014
Melanoma Research Alliance (MRA)-Amgen
Amgen-MRA Established Investigator Academic-Industry Partnership AwardIn collaboration with Amgen, applications are solicited for preclinical or correlative laboratory studies related to the therapeutic potential of oncolytic virus immunotherapy in melanoma, alone or in combination with immune modulators or targeted therapies. A letter of support from Amgen is required at the time of application. Amgen funds will match MRA funds.
Amount: $100,000/ year for 2-3 years
Deadline: November 21, 2014
Melanoma Research Alliance (MRA)
MRA Team Science Academic-Industry Partnership AwardsThese awards are designed to facilitate progress via interactions between the academic and industrial research sectors in the team setting, and will be co-funded by MRA and an industrial collaborator whose involvement is essential to the project. Each team must include at least one Young Investigator as a co-investigator. An investigator may only be the designated Young Investigator on one proposal in the team science category. However, a Young Investigator Award applicant may be the designated Young Investigator on only one team science application. Applications should include a letter of support from industry to MRA to support the project for the full term of the award.
Amount: $500,000 over 2-3 years
Deadline: November 21, 2014
Sidney Kimmel Foundation for Cancer Research
Kimmel Scholar AwardThe Kimmel Foundation is seeking accomplished young investigators dedicated to a career in cancer research. Applications are limited to those who achieved the equivalent rank of Assistant Professor on or after July, 2011.
These awards are designed for researchers who do not yet have their own R01 funding. Amount: $100,00/ year for 2 years
Deadline: December 3, 2014
Sidney Kimmel Foundation for Cancer Research
Kimmel Translational Science AwardThe Kimmel Foundation provides up to five additional awards specifically for physicians engaged in translational science.
Candidates must not hold R01 funding for the laboratory component of their cancer research. Applicants must
have achieved the rank of Assistant Professor on or after July, 2010Amount: $100,000/ year for 2 years
Deadline: December 3, 2014
